Effects of Oral Sildenafil on Mortality in Adults With PAH
Status:
Completed
Trial end date:
2021-02-26
Target enrollment:
Participant gender:
Summary
This is a blinded study in adult patients with PAH evaluating the relative effects of
sildenafil on mortality when administered at the three doses (80 mg, 20 mg or 5 mg, all three
times per day [TID]). In addition, the relative effects on clinical worsening and 6-minute
walking distance (6MWD) will be assessed.